{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:11:53Z","timestamp":1784157113903,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","award":["NNF20OC0064556"],"award-info":[{"award-number":["NNF20OC0064556"]}],"id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Heart Centre, Rigshospitalet, Denmark"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pulmonary hypertension (PH) is classified into five clinical diagnostic groups, including group 1 [idiopathic pulmonary arterial hypertension (IPAH) and connective tissue disease-associated PAH (CTD-aPAH)] and group 4 (chronic thromboembolic pulmonary hypertension (CTEPH)). PH is a progressive, life-threatening, incurable disease. The pathological mechanisms underlying PH remain elusive; recent evidence has revealed that abnormal metabolic activities in the endothelium may play a crucial role. This research introduces a novel approach for studying PH endothelial function, building on the genome-scale metabolic reconstruction of the endothelial cell (EC) to investigate intracellular metabolism. We demonstrate that the intracellular metabolic activities of ECs in PH patients cluster into four phenotypes independent of the PH diagnosis. Notably, the disease severity differs significantly between the metabolic phenotypes, suggesting their clinical relevance. The significant metabolic differences between the PH phenotypes indicate that they may require different therapeutic interventions. In addition, diagnostic capabilities enabling their identification is warranted to investigate whether this opens a novel avenue of precision medicine.<\/jats:p>","DOI":"10.1038\/s41598-022-17374-x","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T19:12:15Z","timestamp":1659467535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["An explorative metabolomic analysis of the endothelium in pulmonary hypertension"],"prefix":"10.1038","volume":"12","author":[{"given":"J.","family":"Carlsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. H.","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Marin de Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. I.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,2]]},"reference":[{"key":"17374_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Galie","year":"2016","unstructured":"Galie, N. et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur. Heart. J. 37, 67\u2013119. https:\/\/doi.org\/10.1093\/eurheartj\/ehv317 (2016).","journal-title":"Eur. Heart. J."},{"key":"17374_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/13993003.01913-2018","volume":"53","author":"G Simonneau","year":"2019","unstructured":"Simonneau, G. et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur. Respir. J. 53, 1. https:\/\/doi.org\/10.1183\/13993003.01913-2018 (2019).","journal-title":"Eur. Respir. J."},{"key":"17374_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088727","volume":"9","author":"Y Zhao","year":"2014","unstructured":"Zhao, Y. et al. Metabolomic heterogeneity of pulmonary arterial hypertension. PLoS ONE 9, e88727. https:\/\/doi.org\/10.1371\/journal.pone.0088727 (2014).","journal-title":"PLoS ONE"},{"key":"17374_CR4","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1161\/circulationaha.116.024602","volume":"135","author":"CJ Rhodes","year":"2017","unstructured":"Rhodes, C. J. et al. Plasma metabolomics implicates modified transfer RNAs and altered bioenergetics in the outcomes of pulmonary arterial hypertension. Circulation 135, 460\u2013475. https:\/\/doi.org\/10.1161\/circulationaha.116.024602 (2017).","journal-title":"Circulation"},{"key":"17374_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4103\/2045-8932.97606","volume":"2","author":"JP Fessel","year":"2012","unstructured":"Fessel, J. P. et al. Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming. Pulm. Circ. 2, 201\u2013213. https:\/\/doi.org\/10.4103\/2045-8932.97606 (2012).","journal-title":"Pulm. Circ."},{"key":"17374_CR6","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1056\/NEJMoa2024277","volume":"384","author":"M Humbert","year":"2021","unstructured":"Humbert, M. et al. Sotatercept for the treatment of pulmonary arterial hypertension. N. Engl. J. Med. 384, 1204\u20131215. https:\/\/doi.org\/10.1056\/NEJMoa2024277 (2021).","journal-title":"N. Engl. J. Med."},{"key":"17374_CR7","doi-asserted-by":"publisher","first-page":"204589401989055","DOI":"10.1177\/2045894019890553","volume":"10","author":"GA Heresi","year":"2020","unstructured":"Heresi, G. A. et al. Plasma metabolomic profile in chronic thromboembolic pulmonary hypertension. Pulm. Circ. 10, 2045894019890553 (2020).","journal-title":"Pulm. Circ."},{"key":"17374_CR8","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.15252\/embj.201696150","volume":"36","author":"BW Wong","year":"2017","unstructured":"Wong, B. W., Marsch, E., Treps, L., Baes, M. & Carmeliet, P. Endothelial cell metabolism in health and disease: impact of hypoxia. Embo. J. 36, 2187\u20132203. https:\/\/doi.org\/10.15252\/embj.201696150 (2017).","journal-title":"Embo. J."},{"key":"17374_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/01.Cir.0000102381.57477.50","volume":"109","author":"R Budhiraja","year":"2004","unstructured":"Budhiraja, R., Tuder, R. M. & Hassoun, P. M. Endothelial dysfunction in pulmonary hypertension. Circulation 109, 159\u2013165. https:\/\/doi.org\/10.1161\/01.Cir.0000102381.57477.50 (2004).","journal-title":"Circulation"},{"key":"17374_CR10","first-page":"183","volume":"1","author":"HA Hadi","year":"2005","unstructured":"Hadi, H. A., Carr, C. S. & Al Suwaidi, J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vascul. Health. Risk. Manag. 1, 183\u2013198 (2005).","journal-title":"Vascul. Health. Risk. Manag."},{"key":"17374_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.vph.2008.06.003","volume":"49","author":"M Humbert","year":"2008","unstructured":"Humbert, M. et al. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. Vascul. Pharmacol. 49, 113\u2013118. https:\/\/doi.org\/10.1016\/j.vph.2008.06.003 (2008).","journal-title":"Vascul. Pharmacol."},{"key":"17374_CR12","first-page":"437","volume":"137","author":"LP Nicod","year":"2007","unstructured":"Nicod, L. P. The endothelium and genetics in pulmonary arterial hypertension. Swiss Med. Wkly. 137, 437\u2013442 (2007).","journal-title":"Swiss Med. Wkly."},{"key":"17374_CR13","doi-asserted-by":"publisher","first-page":"204589401876462","DOI":"10.1177\/2045894018764629","volume":"8","author":"A Dummer","year":"2018","unstructured":"Dummer, A. et al. Endothelial dysfunction in pulmonary arterial hypertension: Loss of cilia length regulation upon cytokine stimulation. Pulm. Circ. 8, 2045894018764629. https:\/\/doi.org\/10.1177\/2045894018764629 (2018).","journal-title":"Pulm. Circ."},{"key":"17374_CR14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.7326\/0003-4819-114-6-464","volume":"114","author":"DJ Stewart","year":"1991","unstructured":"Stewart, D. J., Levy, R. D., Cernacek, P. & Langleben, D. Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?. Ann. Intern. Med. 114, 464\u2013469. https:\/\/doi.org\/10.7326\/0003-4819-114-6-464 (1991).","journal-title":"Ann. Intern. Med."},{"key":"17374_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1056\/nejm199207093270202","volume":"327","author":"BW Christman","year":"1992","unstructured":"Christman, B. W. et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N. Engl. J. Med. 327, 70\u201375. https:\/\/doi.org\/10.1056\/nejm199207093270202 (1992).","journal-title":"N. Engl. J. Med."},{"key":"17374_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1165\/rcmb.2010-0317OC","volume":"45","author":"L Tu","year":"2011","unstructured":"Tu, L. et al. Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension. Am. J. Respir. Cell. Mol. Biol. 45, 311\u2013322. https:\/\/doi.org\/10.1165\/rcmb.2010-0317OC (2011).","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"17374_CR17","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.201709-1835OC","volume":"198","author":"Z Dai","year":"2018","unstructured":"Dai, Z. et al. Endothelial and smooth muscle cell interaction via FoxM1 signaling mediates vascular remodeling and pulmonary hypertension. Am. J. Respir. Crit. Care. Med. 198, 788\u2013802. https:\/\/doi.org\/10.1164\/rccm.201709-1835OC (2018).","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"17374_CR18","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1097\/sla.0000000000003307","volume":"272","author":"HH Henriksen","year":"2020","unstructured":"Henriksen, H. H. et al. Metabolic systems analysis of shock-induced endotheliopathy (SHINE) in trauma: a new research paradigm. Ann. Surg. 272, 1140\u20131148. https:\/\/doi.org\/10.1097\/sla.0000000000003307 (2020).","journal-title":"Ann. Surg."},{"issue":"1","key":"17374_CR19","doi-asserted-by":"publisher","first-page":"6811","DOI":"10.1038\/s41598-018-25015-5","volume":"8","author":"S McGarrity","year":"2018","unstructured":"McGarrity, S. et al. Metabolic systems analysis of LPS induced endothelial dysfunction applied to sepsis patient stratification. Sci. Rep. 8(1), 6811 (2018).","journal-title":"Sci. Rep."},{"key":"17374_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fcvm.2016.00010","volume":"3","author":"S McGarrity","year":"2016","unstructured":"McGarrity, S., Halldorsson, H., Palsson, S., Johansson, P. I. & Rolfsson, O. Understanding the causes and implications of endothelial metabolic variation in cardiovascular disease through genome-scale metabolic modeling. Front. Cardiovasc. Med. 3, 10 (2016).","journal-title":"Front. Cardiovasc. Med."},{"key":"17374_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12890-017-0521-4","volume":"17","author":"TM Berghaus","year":"2017","unstructured":"Berghaus, T. M., Kutsch, J., Faul, C., von Scheidt, W. & Schwaiblmair, M. The association of N-terminal pro-brain-type natriuretic peptide with hemodynamics and functional capacity in therapy-naive precapillary pulmonary hypertension: results from a cohort study. BMC Pulm. Med. 17, 167. https:\/\/doi.org\/10.1186\/s12890-017-0521-4 (2017).","journal-title":"BMC Pulm. Med."},{"key":"17374_CR22","doi-asserted-by":"publisher","first-page":"7104","DOI":"10.1038\/s41467-021-27326-0","volume":"12","author":"S Kariotis","year":"2021","unstructured":"Kariotis, S. et al. Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood. Nat. Commun. 12, 7104. https:\/\/doi.org\/10.1038\/s41467-021-27326-0 (2021).","journal-title":"Nat. Commun."},{"key":"17374_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fbioe.2019.00172","volume":"7","author":"D Wu","year":"2019","unstructured":"Wu, D. & Birukov, K. Endothelial cell mechano-metabolomic coupling to disease states in the lung microvasculature. Front. Bioeng. Biotechnol. 7, 172. https:\/\/doi.org\/10.3389\/fbioe.2019.00172 (2019).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"17374_CR24","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1073\/pnas.1222878110","volume":"110","author":"J Seok","year":"2013","unstructured":"Seok, J. et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 110, 3507\u20133512. https:\/\/doi.org\/10.1073\/pnas.1222878110 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"17374_CR25","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1089\/ars.2007.1674","volume":"9","author":"TK Hunt","year":"2007","unstructured":"Hunt, T. K. et al. Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms. Antioxid. Redox. Signal. 9, 1115\u20131124. https:\/\/doi.org\/10.1089\/ars.2007.1674 (2007).","journal-title":"Antioxid. Redox. Signal."},{"key":"17374_CR26","doi-asserted-by":"publisher","first-page":"21161","DOI":"10.1074\/jbc.M113.474619","volume":"288","author":"GX Ruan","year":"2013","unstructured":"Ruan, G. X. & Kazlauskas, A. Lactate engages receptor tyrosine kinases Axl, Tie2, and vascular endothelial growth factor receptor 2 to activate phosphoinositide 3-kinase\/Akt and promote angiogenesis. J. Biol. Chem. 288, 21161\u201321172. https:\/\/doi.org\/10.1074\/jbc.M113.474619 (2013).","journal-title":"J. Biol. Chem."},{"key":"17374_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033418","volume":"7","author":"P Sonveaux","year":"2012","unstructured":"Sonveaux, P. et al. Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis. PLoS ONE 7, e33418. https:\/\/doi.org\/10.1371\/journal.pone.0033418 (2012).","journal-title":"PLoS ONE"},{"key":"17374_CR28","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1158\/0008-5472.Can-10-2828","volume":"71","author":"F V\u00e9gran","year":"2011","unstructured":"V\u00e9gran, F., Boidot, R., Michiels, C., Sonveaux, P. & Feron, O. Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-\u03baB\/IL-8 pathway that drives tumor angiogenesis. Cancer Res. 71, 2550\u20132560. https:\/\/doi.org\/10.1158\/0008-5472.Can-10-2828 (2011).","journal-title":"Cancer Res."},{"key":"17374_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1161\/circresaha.115.301130","volume":"115","author":"R Paulin","year":"2014","unstructured":"Paulin, R. & Michelakis, E. D. The metabolic theory of pulmonary arterial hypertension. Circ. Res. 115, 148\u2013164. https:\/\/doi.org\/10.1161\/circresaha.115.301130 (2014).","journal-title":"Circ. Res."},{"key":"17374_CR30","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.cmet.2014.01.004","volume":"19","author":"G Sutendra","year":"2014","unstructured":"Sutendra, G. & Michelakis, E. D. The metabolic basis of pulmonary arterial hypertension. Cell Metab. 19, 558\u2013573. https:\/\/doi.org\/10.1016\/j.cmet.2014.01.004 (2014).","journal-title":"Cell Metab."},{"key":"17374_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2049-3002-2-19","volume":"2","author":"D Verdegem","year":"2014","unstructured":"Verdegem, D., Moens, S., Stapor, P. & Carmeliet, P. Endothelial cell metabolism: parallels and divergences with cancer cell metabolism. Cancer Metab. 2, 19. https:\/\/doi.org\/10.1186\/2049-3002-2-19 (2014).","journal-title":"Cancer Metab."},{"issue":"10","key":"17374_CR32","doi-asserted-by":"publisher","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","volume":"24","author":"M Schieber","year":"2014","unstructured":"Schieber, M. & Chandel, N. S. ROS function in redox signaling and oxidative stress. Curr Biol. 24(10), R453\u2013R462 (2014).","journal-title":"Curr Biol."},{"key":"17374_CR33","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1161\/circulationaha.114.006980","volume":"131","author":"BA Maron","year":"2015","unstructured":"Maron, B. A. & Leopold, J. A. Emerging concepts in the molecular basis of pulmonary arterial hypertension: Part II: neurohormonal signaling contributes to the pulmonary vascular and right ventricular pathophenotype of pulmonary arterial hypertension. Circulation 131, 2079\u20132091. https:\/\/doi.org\/10.1161\/circulationaha.114.006980 (2015).","journal-title":"Circulation"},{"key":"17374_CR34","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1161\/01.cir.102.8.865","volume":"102","author":"N Nagaya","year":"2000","unstructured":"Nagaya, N. et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 102, 865\u2013870. https:\/\/doi.org\/10.1161\/01.cir.102.8.865 (2000).","journal-title":"Circulation"},{"key":"17374_CR35","doi-asserted-by":"crossref","unstructured":"Richelle, A. et al. What does your cell really do? Model-based assessment of mammalian cells metabolic functionalities using omics data. bioRxiv. 2020:2020.04.26.057943.","DOI":"10.1101\/2020.04.26.057943"},{"key":"17374_CR36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1164\/rccm.201710-2093PP","volume":"198","author":"JM Elinoff","year":"2018","unstructured":"Elinoff, J. M. et al. ()2018 Challenges in pulmonary hypertension: controversies in treating the tip of the iceberg. A joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium report. Am. J. Respir. Crit. Care. Med. 198, 166\u2013174. https:\/\/doi.org\/10.1164\/rccm.201710-2093PP (2018).","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"17374_CR37","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/rcm.7834","volume":"31","author":"T Nemkov","year":"2017","unstructured":"Nemkov, T., Hansen, K. C. & D\u2019Alessandro, A. A three-minute method for high-throughput quantitative metabolomics and quantitative tracing experiments of central carbon and nitrogen pathways. Rapid. Commun. Mass Spectrom. 31, 663\u2013673. https:\/\/doi.org\/10.1002\/rcm.7834 (2017).","journal-title":"Rapid. Commun. Mass Spectrom."},{"key":"17374_CR38","unstructured":"Catalin, E., & Doneanu W. C. Application note 2011, 720004042en. UPLC\/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes. https:\/\/www.waters.com\/waters\/library.htm?locale=en_US&lid=134636355) (2020)."},{"key":"17374_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.chroma.2017.04.052","volume":"1503","author":"LG Johnsen","year":"2017","unstructured":"Johnsen, L. G., Skou, P. B., Khakimov, B. & Bro, R. Gas chromatography - mass spectrometry data processing made easy. J. Chromatogr. A. 1503, 57\u201364. https:\/\/doi.org\/10.1016\/j.chroma.2017.04.052 (2017).","journal-title":"J. Chromatogr. A."},{"key":"17374_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","volume":"28","author":"DJ Stekhoven","year":"2012","unstructured":"Stekhoven, D. J. & B\u00fchlmann, P. MissForest\u2013non-parametric missing value imputation for mixed-type data. Bioinformatics 28, 112\u2013118. https:\/\/doi.org\/10.1093\/bioinformatics\/btr597 (2012).","journal-title":"Bioinformatics"},{"key":"17374_CR41","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nprot.2011.308","volume":"6","author":"J Schellenberger","year":"2011","unstructured":"Schellenberger, J. et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v20. Nat. Protoc. 6, 1290\u20131307. https:\/\/doi.org\/10.1038\/nprot.2011.308 (2011).","journal-title":"Nat. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17374-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17374-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:31:58Z","timestamp":1669354318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17374-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,2]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["17374"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-17374-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,2]]},"assertion":[{"value":"3 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JC declare Institutional Research Grant (outside this work) and Advisory boards (institution, outside this work) from Janssen-Cilag AB, and speaker fees (outside this work) from Ferrer Interational SA. HHH, IMdM, PIJ declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13284"}}